Induction of micronuclei by four cytostatic compounds in human hematopoietic stem cells and human lymphoblastoid TK6 cells

Scientific Reports
Henning HintzscheHelga Stopper

Abstract

For mutagenicity testing, primary lymphocytes or mammalian cell lines are employed. However, the true target for carcinogenic action of mutagenic chemicals may be stem cells. Since hematopoietic cancers induced by chemical agents originate at the hematopoietic stem cell (HSC) stage and since one of the side effects of chemotherapeutic cancer treatment is the induction of secondary tumors, often leukemias, HSC may be a suitable cell system. We compared the sensitivity of HSC with the genotoxicity testing cell line TK6 for chromosomal mutations. HSC were less sensitive than TK6 cells for the genotoxic effects of the model genotoxins and chemotherapeutic agents doxorubicin, vinblastine, methyl methanesulfonate (MMS) and equally sensitive for mitomycin C (MMC). However, loss of viability after mitomycin C treatment was higher in HSC than in TK6 cells. Among the factors that may influence sensitivity for genomic damage, the generation or response to reactive oxygen species (ROS) and the effectiveness of DNA damage response can be discussed. Here we show that HSC can be used in a standard micronucleus test protocol for chromosomal mutations and that their sensitivity was not higher than that of a classical testing cell line.

References

Feb 1, 1985·Mutation Research·M Fenech, A A Morley
Feb 21, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Diane J AbernethyBrenda Faiola
Jul 23, 2008·Methods in Molecular Biology·Michael Fenech
May 1, 2010·The American Journal of Pathology·Stewart Sell
Jun 25, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Bas J Blaauboer
Jul 17, 2010·Journal of the National Cancer Institute·Debra L FriedmanJoseph P Neglia
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Raoul C ReulenUNKNOWN British Childhood Cancer Survivor Study Steering Group
Jan 17, 2012·Chemical Research in Toxicology·Nynke I KramerJoop L M Hermens
Feb 5, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Jessica J W BroedersJoop L M Hermens
Apr 16, 2014·Mutation Research. Reviews in Mutation Research·David A EastmondBabasaheb Sonawane
Sep 23, 2014·Trends in Cell Biology·Andrew C White, William E Lowry
Nov 19, 2014·International Journal of Molecular Sciences·Saranya P WylesTimothy J Nelson
Aug 15, 2015·Oxidative Medicine and Cellular Longevity·Sébastien SartYan Li
Jan 14, 2016·Journal of Cell Science·Christine HofstetterMatthias Becker
Jan 16, 2016·Stem Cell Reports·Timothy M ChlonSusanne I Wells
Jan 18, 2016·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Javier RevolloVasily N Dobrovolsky
Feb 8, 2016·Mutation Research·Mathieu von JoestHan Li
Mar 11, 2016·Cellular and Molecular Life Sciences : CMLS·Paola RebuzziniSilvia Garagna
Apr 3, 2016·Mutation Research. Reviews in Mutation Research·Narendra P Singh
Jul 6, 2016·Archives of Toxicology·M GleiW Schlörmann
Aug 20, 2016·Archives of Toxicology·Mariona TerradasAnna Genescà
Sep 12, 2016·Cellular and Molecular Life Sciences : CMLS·Xuemei FuYang Xu
Oct 7, 2016·Radiation Research·Katharina GläserHenning Hintzsche
Mar 28, 2017·Mutation Research. Reviews in Mutation Research·Henning HintzscheUNKNOWN Working Group “In vitro micronucleus test”, Gesellschaft für Umwelt-Mutationsforschung (GUM, German-speaking section of the
Apr 2, 2017·Free Radical Biology & Medicine·Jean Cadet, Kelvin J A Davies

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
protein-assay

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.